The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Treatment-related hypertension (HTN) as a predictive biomarker for clinical outcomes in patients (pts) with advanced pancreas cancer (APCA) treated with bevacizumab (B): A pooled analysis of four prospective clinical trials.
Ludmila Katherine Martin
No relevant relationships to disclose
Lai Wei
No relevant relationships to disclose
Katherine Van Loon
No relevant relationships to disclose
Renuka V. Iyer
No relevant relationships to disclose
Shubham Pant
No relevant relationships to disclose
David R. Fogelman
No relevant relationships to disclose
Andrew H. Ko
No relevant relationships to disclose
Tanios S. Bekaii-Saab
Consultant or Advisory Role - Genentech/Roche